These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21286080)

  • 61. Mammographic features in infertile women as a potential risk for breast cancer: a preliminary study.
    Meggiorini ML; Cipolla V; Rech F; Labi L; Vestri A; de Felice C
    Eur J Gynaecol Oncol; 2012; 33(1):51-5. PubMed ID: 22439405
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mammographic screening: efficacy and guidelines.
    Smart CR
    Curr Opin Radiol; 1992 Oct; 4(5):108-17. PubMed ID: 1388042
    [TBL] [Abstract][Full Text] [Related]  

  • 63. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Physician recommendations for screening mammography: results of a survey using clinical vignettes.
    Hamblin JE
    J Fam Pract; 1991 May; 32(5):472-7. PubMed ID: 2022935
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Benefit to Radiation Risk of Breast-specific Gamma Imaging Compared with Mammography in Screening Asymptomatic Women with Dense Breasts.
    Hendrick RE; Tredennick T
    Radiology; 2016 Nov; 281(2):583-588. PubMed ID: 27257949
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Screening for breast cancer with mammography.
    Gøtzsche PC; Nielsen M
    Cochrane Database Syst Rev; 2009 Oct; (4):CD001877. PubMed ID: 19821284
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
    Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Breast MRI screening for average-risk women: A monte carlo simulation cost-benefit analysis.
    Mango VL; Goel A; Mema E; Kwak E; Ha R
    J Magn Reson Imaging; 2019 Jun; 49(7):e216-e221. PubMed ID: 30632645
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Benefits of screening mammography: a review for the primary care physician.
    Reichle JL
    South Med J; 1998 Jun; 91(6):510-7. PubMed ID: 9634110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
    Nelson HD; Fu R; Cantor A; Pappas M; Daeges M; Humphrey L
    Ann Intern Med; 2016 Feb; 164(4):244-55. PubMed ID: 26756588
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparative Benefit-to-Radiation Risk Ratio of Molecular Breast Imaging, Two-Dimensional Full-Field Digital Mammography with and without Tomosynthesis, and Synthetic Mammography with Tomosynthesis.
    Brown M; Covington MF
    Radiol Imaging Cancer; 2019 Sep; 1(1):e190005. PubMed ID: 33778669
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The influence of risk factors on breast carcinoma screening of Medicare-insured older women. National Cancer Institute Breast Cancer Screening Consortium.
    Roetzheim R; Fox SA; Leake B; Houn F
    Cancer; 1996 Dec; 78(12):2526-34. PubMed ID: 8952561
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ultrasound for breast cancer screening and staging.
    Gordon PB
    Radiol Clin North Am; 2002 May; 40(3):431-41. PubMed ID: 12117185
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A meta-analysis of mammographic screening with and without clinical breast examination.
    Hamashima C; Ohta K; Kasahara Y; Katayama T; Nakayama T; Honjo S; Ohnuki K
    Cancer Sci; 2015 Jul; 106(7):812-8. PubMed ID: 25959787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Siu AL;
    Ann Intern Med; 2016 Feb; 164(4):279-96. PubMed ID: 26757170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review.
    Nothacker M; Duda V; Hahn M; Warm M; Degenhardt F; Madjar H; Weinbrenner S; Albert US
    BMC Cancer; 2009 Sep; 9():335. PubMed ID: 19765317
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Breast cancer screening among women younger than age 50: a current assessment of the issues.
    Smith RA
    CA Cancer J Clin; 2000; 50(5):312-36. PubMed ID: 11075240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.